296 related articles for article (PubMed ID: 14689107)
1. Combination versus Monotherapy as Initial Treatment in Hypertension.
Holzgreve H
Herz; 2003 Dec; 28(8):725-32. PubMed ID: 14689107
[TBL] [Abstract][Full Text] [Related]
2. Low-dose fixed combination of bisoprolol/hydrochlorothiazide as first line for hypertension: a review of the rationale and clinical evidence.
Papadopoulos DP; Papademetriou V
Angiology; 2009; 60(5):601-7. PubMed ID: 19028769
[TBL] [Abstract][Full Text] [Related]
3. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
4. Managing hypertension: a question of STRATHE.
Zannad F
J Hum Hypertens; 2005 Jun; 19 Suppl 1():S3-7. PubMed ID: 16075031
[TBL] [Abstract][Full Text] [Related]
5. [Value of combination therapy in treatment of hypertension].
Kreutz R
Krankenpfl J; 2005; 43(7-10):255. PubMed ID: 16515324
[No Abstract] [Full Text] [Related]
6. A randomised control trial on sequential drug monotherapy versus conventional step care therapy in the treatment of mild to moderate hypertension.
Jagadevan R; Cherian AM; Jeyaseelan L; Peter JV
J Assoc Physicians India; 1999 Feb; 47(2):173-6. PubMed ID: 10999082
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of therapeutic strategies in the management of hypertension].
Waeber B
Curr Med Res Opin; 2005; 21 Suppl 5():S13-6. PubMed ID: 16197647
[TBL] [Abstract][Full Text] [Related]
8. [Initial combination treatment of hypertension].
Düsing R
MMW Fortschr Med; 2004 Nov; 146(47):46-8. PubMed ID: 15624658
[TBL] [Abstract][Full Text] [Related]
9. [Fixed-dose combinations in the first line of antihypertensive therapy].
Urbán L; Mészáros A
Acta Pharm Hung; 2007; 77(3):180-4. PubMed ID: 18019783
[TBL] [Abstract][Full Text] [Related]
10. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
Abe M; Okada K; Matsumoto K
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
[TBL] [Abstract][Full Text] [Related]
13. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
Waeber B
J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
[TBL] [Abstract][Full Text] [Related]
14. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
15. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J
J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
[TBL] [Abstract][Full Text] [Related]
16. [Combination therapy in the therapeutic strategy of arterial hypertension].
Chamontin B; Amar J
J Hum Hypertens; 1995 Aug; 9 Suppl 4():S35-9. PubMed ID: 7674272
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
[TBL] [Abstract][Full Text] [Related]
18. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto K
Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
[TBL] [Abstract][Full Text] [Related]
19. [When blood pressure control is a problem. Refractory hypertension is rare].
Offers E; Kolloch R
MMW Fortschr Med; 2002 Nov; 144(46):42-4, 46. PubMed ID: 12534081
[TBL] [Abstract][Full Text] [Related]
20. Low-dose combinations versus monotherapies in the treatment of hypertension.
Waeber B; Brunner HR
J Hypertens Suppl; 1997 Mar; 15(2):S17-20. PubMed ID: 9218193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
